Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.11/Share

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.11), versus ($0.18) reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
• Adobe (ADBE) PT Raised to $250 at Baird